Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 74Colorectal Neoplasms 41Central Nervous System Neoplasms 37Colonic Neoplasms 36Rectal Neoplasms 34Glioblastoma 23Carcinoma, Non-Small-Cell Lung 21Gliosarcoma 20Stomach Neoplasms 18Lung Neoplasms 18Pancreatic Neoplasms 16Head and Neck Neoplasms 16Sarcoma 14Ovarian Neoplasms 14Squamous Cell Carcinoma of Head and Neck 13Prostatic Neoplasms 12Neoplasm Metastasis 11Melanoma 11Esophageal Neoplasms 11Carcinoma, Ovarian Epithelial 11Carcinoma, Intraductal, Noninfiltrating 11Astrocytoma 11Fallopian Tube Neoplasms 10Brain Neoplasms 10Uterine Cervical Neoplasms 9Kidney Neoplasms 9Breast Carcinoma In Situ 9Liver Neoplasms 8Breast Neoplasms, Male 8Adenocarcinoma Of Esophagus 8

Interventions

Temozolomide 11Cyclophosphamide 11Radiotherapy 7Magnetic Resonance Spectroscopy 6Filgrastim 6Cisplatin 6Vincristine 5Etoposide 5Carboplatin 5antineoplaston AS 2-1 4antineoplaston A10 4sargramostim 3Thiotepa 3Melphalan 3Carmustine 3Automobiles 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3gallium Ga 68 dotatate 2fludarabine 2dactolisib 2aldesleukin 2Thalidomide 2TH 302 2Surveys and Questionnaires 2Paclitaxel 2Irinotecan 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Gadolinium DTPA 2Everolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors, Primitive × Chemotherapy, Adjuvant × Clear all
NCT00006258 2013-07-18

Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma

National Cancer Institute (NCI)

Phase 2 Completed
CNS

Ependymoma, Medulloblastoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡